l-hydroxy arginine

L-hydroxy Arginine is a substrate for nitric oxide synthase in the catabolism of L-arginine to form nitric oxide. It has been used as a biomarker for reduced nitric oxide formation in patients with cardiovascular disease and metabolic syndrome.

L-Hydroxy arginine dihydrochloride is a stable intermediate in the decomposition metabolism of L-arginine.

nor-NOHA acetate (Nω-Hydroxy-nor-L-arginine acetate) is a reversible inhibitor of arginase with anti-leukemic activity, effective in treating endothelial dysfunction, immunosuppression, and metabolism regulation.

Nω-Hydroxy-nor-L-Arginine Dihydrochloride is a competitive and reversible inhibitor of arginase

NG-Hydroxy-L-arginine acetate (NOHA acetate) acts as a crucial physiological inhibitor of arginase, playing a vital role in the conversion of arginine to nitric oxide and citrulline via nitric oxide synthase.

nor-NOHA monoacetate (Nω-Hydroxy-nor-L-arginine) is a highly potent and selective arginase inhibitor. nor-NOHA monoacetate inhibits rat hepatic arginase and inhibits the hydrolysis of L-arginine, which can be used to study cardiovascular and obstructive airway diseases.

N(5)-Hydroxy-L-arginine is an antibiotic that exhibits activity against both Gram-positive and Gram-negative bacteria.

N(ω)-Hydroxyarginine (N(ω)-Hydroxy-L-arginine) is a nucleoside metabolite.

Nor-N-omega-hydroxy-L-arginine-CoA (Nor-N-omega-hydroxy-L-arginine-coenzyme A) is a derivative of coenzyme A.

N-Omega-hydroxy-L-arginine-CoA (N-Omega-hydroxy-L-arginine-coenzyme A) is a derivative of coenzyme A.

Dinor-Nω-Hydroxy-L-arginine-CoA (Dinor-Nω-Hydroxy-L-arginine-coenzyme A) is a derivative of coenzyme A.